- Organization Overview
- Dean’s Office
- Dean’s Office Overview
- PharmD Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Pharmacy Practice Partnerships
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Patient Care
Resistant bacteria meet their match with custom antibiotics
By Levi Gadye / Mon Oct 26, 2020
Paul Gunning (Cell Image Library)
Bacterial resistance is a growing problem. About 2.8 million people are infected by resistant bacteria or fungi each year, leading to 35,000 deaths. Scientists at the UCSF School of Pharmacy have shown that engineering small molecular changes into some antibiotics can restore their effectiveness in stopping the growth of drug-resistant bacteria.
Ian Seiple, PhD, faculty member in the School’s Department of Pharmaceutical Chemistry and the UCSF Cardiovascular Research Institute, systematically modified a group of antibiotics to skirt the defenses of drug-resistant bacteria.
Seiple’s revamped antibiotics beat back these bacteria. He then worked with James Fraser, PhD, faculty member in the Department of Bioengineering and Therapeutic Sciences, to understand how these modifications work.
He provides an overview of the research, which was published September 23 in Nature, in the video below.
As recently as 100 years ago every minor injury or routine surgery came with significant risk of infection or even death. The discovery of antibiotics changed that, and they are now essential components of modern medicine. But many bacteria are becoming resistant to these drugs, and we aren’t discovering enough new ones to keep up. My laboratory is building new molecules from simple chemical building blocks, much like Legos, to revitalize antibiotics that haven’t yet reached their full potential. We recently used this approach to improve antibiotics known as streptogramins, which some bacteria are able to deactivate. We built new streptogramins that have a molecular bump that prevents deactivation, overcoming resistance. Working with the Fraser Lab, we are visualizing how these new streptogramins work and are now applying insights from this research to improve other antibiotics. It’s our hope that these efforts will keep medicine one or two steps ahead of deadly, resistant bacteria for decades to come.
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.